Enliven Therapeutics, Inc (ELVN) Tops Q4 EPS by 6c

Enliven Therapeutics, Inc (NASDAQ: ELVN) reported Q4 EPS of ($0.46), $0.06 better than the analyst estimate of ($0.52).

For earnings history and earnings-related data on Enliven Therapeutics, Inc (ELVN) click here.

You May Also Be Interested In

• Anthropic Signs $35b Cloud Deal With Lambda In Texas: WSJ
• NIO delivers 35,836 vehicles in August, up 14.5% year-over-year
• Hyper Bit Technologies Announces Closing of Private Placement